| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/bioinformatics/NiuYZLXMWD14 |
| P356 | DOI | 10.1093/BIOINFORMATICS/BTT755 |
| P932 | PMC publication ID | 3967115 |
| P698 | PubMed publication ID | 24371154 |
| P5875 | ResearchGate publication ID | 259473497 |
| P2093 | author name string | Li Ding | |
| Michael C Wendl | |||
| Charles Lu | |||
| Michael D McLellan | |||
| Beifang Niu | |||
| Qunyuan Zhang | |||
| Kai Ye | |||
| Mingchao Xie | |||
| P2860 | cites work | MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast | Q42427955 |
| New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. | Q55033068 | ||
| Prognostic factors for patients with sarcomas of the pelvic bones | Q74256533 | ||
| Integrated genomic characterization of endometrial carcinoma | Q28289962 | ||
| A novel approach for characterizing microsatellite instability in cancer cells | Q34720965 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microsatellite | Q265193 |
| P304 | page(s) | 1015-1016 | |
| P577 | publication date | 2013-12-25 | |
| P1433 | published in | Bioinformatics | Q4914910 |
| P1476 | title | MSIsensor: microsatellite instability detection using paired tumor-normal sequence data | |
| P478 | volume | 30 |
| Q36959154 | A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer |
| Q38741312 | A molecular portrait of microsatellite instability across multiple cancers |
| Q58695959 | A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumours |
| Q97537443 | Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8-MCM9 complex and compromises DNA mismatch repair in cancer cells |
| Q90273068 | Accurately estimating the length distributions of genomic micro-satellites by tumor purity deconvolution |
| Q96645530 | Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma |
| Q90941481 | Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes |
| Q90085893 | An integrated molecular profile of endometrioid ovarian cancer |
| Q92984431 | Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression |
| Q59411242 | Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing |
| Q30854226 | Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer |
| Q38968819 | Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival |
| Q40505485 | Classification and characterization of microsatellite instability across 18 cancer types |
| Q50116991 | Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer |
| Q90697662 | Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer |
| Q96952513 | Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma |
| Q91402180 | Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer |
| Q57796526 | Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma |
| Q52602398 | Comprehensive Characterization of Cancer Driver Genes and Mutations. |
| Q91599315 | Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer |
| Q64061292 | Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens |
| Q90714354 | DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers |
| Q40468182 | Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. |
| Q89511089 | Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark |
| Q36768782 | Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy |
| Q47713578 | Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. |
| Q37247809 | Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma. |
| Q89849938 | Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions |
| Q47584566 | Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer. |
| Q91711174 | Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response |
| Q93096373 | Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma |
| Q90256113 | Genome doubling shapes the evolution and prognosis of advanced cancers |
| Q63977685 | Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch Syndrome |
| Q92399556 | Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy |
| Q92002547 | Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases |
| Q90019501 | Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion |
| Q50115014 | HER kinase inhibition in patients with HER2- and HER3-mutant cancers |
| Q91452763 | High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants |
| Q93172369 | High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers |
| Q64944737 | How I treat MSI cancers with advanced disease. |
| Q91813329 | Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study |
| Q37149773 | Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF |
| Q64060079 | Identification of Targetable Lesions in Anaplastic Thyroid Cancer by Genome Profiling |
| Q40093976 | Identification of neutral tumor evolution across cancer types. |
| Q90383103 | Immune Checkpoint Markers in Neuroendocrine Carcinoma of the Digestive System |
| Q47664722 | Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations. |
| Q92461421 | Immunotherapy in colorectal cancer: rationale, challenges and potential |
| Q102061307 | Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology |
| Q96640142 | Label-free, automated classification of microsatellite status in colorectal cancer by infrared imaging |
| Q88929581 | Landscape of Microsatellite Instability Across 39 Cancer Types |
| Q42696727 | MIRMMR: binary classification of microsatellite instability using methylation and mutations |
| Q59796136 | MSIpred: a python package for tumor microsatellite instability classification from tumor mutation annotation data using a support vector machine |
| Q90326788 | MSIsensor-pro: Fast, Accurate, and Matched-normal-sample-free Detection of Microsatellite Instability |
| Q35996745 | MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic Mutations |
| Q58096218 | Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer |
| Q95642026 | Microsatellite Instability-Related ACVR2A Mutations Partially Account for Decreased Lymph Node Metastasis in MSI-H Gastric Cancers |
| Q90749821 | Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer |
| Q90448647 | Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives |
| Q55264193 | Microsatellite instability in prostate cancer by PCR or next-generation sequencing. |
| Q58790068 | Mismatch repair-based stratification for immune checkpoint blockade therapy |
| Q60958385 | Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer |
| Q99727569 | Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis |
| Q92152185 | Molecular profiling and molecular classification of endometrioid ovarian carcinomas |
| Q91341271 | Molecular subtypes of pancreatic cancer |
| Q94593616 | Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer |
| Q33722799 | Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1 |
| Q50222046 | Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. |
| Q64386735 | Mutational burden and signatures in 4,000 Japanese cancers provide insights into tumorigenesis and response to therapy |
| Q38798543 | Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. |
| Q97546037 | Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens |
| Q55209598 | Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors. |
| Q90044434 | Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade |
| Q37702544 | Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS. |
| Q53075272 | Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. |
| Q95934157 | Phase and context shape the function of composite oncogenic mutations |
| Q91641913 | PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer |
| Q36286293 | Precision oncology: Charting a path forward to broader deployment of genomic profiling |
| Q89983786 | Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis |
| Q58101915 | Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies |
| Q89720874 | Proteogenomic Characterization of Endometrial Carcinoma |
| Q92667826 | Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma |
| Q37588208 | Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma. |
| Q90388731 | Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer |
| Q37130135 | Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels |
| Q92132868 | Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes |
| Q92432373 | Sclerosing epithelioid mesenchymal neoplasm of the pancreas - a proposed new entity |
| Q38996594 | Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment. |
| Q90468856 | The Evolutionary Origins of Recurrent Pancreatic Cancer |
| Q52733226 | The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas. |
| Q48143437 | The Value of Cell-free DNA for Molecular Pathology |
| Q92514575 | Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome |
| Q91967463 | Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families |
| Q102061305 | Tumor-derived mutations in postoperative plasma of colorectal cancer with microsatellite instability |
| Q55339783 | TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome. |
| Q91776847 | Tumour lineage shapes BRCA-mediated phenotypes |
| Q64063969 | Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade |
| Q87825229 | Universal screening for microsatellite instability in colorectal cancer in the clinical genomics era: new recommendations, methods, and considerations |
| Q91665239 | Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling |
| Q89326750 | Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma |
| Q92067194 | Whole genome DNA sequencing provides an atlas of somatic mutagenesis in healthy human cells and identifies a tumor-prone cell type |
| Q88910053 | Whole-Genome Sequencing in Cancer |
| Q39060449 | Whole-genome landscapes of major melanoma subtypes. |
Search more.